FamilyFOCUS at Dana-Farber
Published in academic literature
App Summary
App Screenshots






Detailed Description
Functionality & Mechanism
Developed at Dana-Farber Cancer Institute, FamilyFOCUS is a support application delivering guidance and practical tools for adult children caring for a parent with cancer. The system presents a curated library of expert-backed content modules focused on common caregiving challenges. These modules deliver information on managing medical logistics, navigating family dynamics, and engaging in advance care planning. The interface facilitates direct access to targeted resources designed to support caregivers throughout the diagnostic and treatment journey.
Evidence & Research Context
- The application's design is grounded in the principles of a patient- and family-centered care model, which extends support to the entire family unit.
- Associated research from the developers emphasizes collaborative practice models that position family caregivers as integral members of the care team.
- This framework acknowledges the significant logistical and emotional burdens on caregivers and aims to provide structured, accessible support to mitigate them.
Intended Use & Scope
This tool is designed specifically for adult children serving as non-professional caregivers for a parent with cancer. Its primary utility is as an adjunct informational and emotional support resource. The application provides psychoeducational content and practical tips; it does not constitute medical advice or formal psychological counseling. Users must consult with healthcare professionals for clinical guidance.
Studies & Publications
Peer-reviewed research associated with this app.
A Patient- and Family-Centered Care Model Paves the Way for a Culture of Quality and Safety
Reid Ponte et al. (2008) · Critical Care Nursing Clinics of North America
Referenced in academic literature; no direct evaluation of the appApp Information
Developer
Dana-Farber Cancer InstituteCategory
Evidence Profile
Published in academic literature
Platforms
Updated
Aug 2025
© 2025 Dana-Farber Cancer Institute